Minichmayr, I. K., Karlsson, M. O., & Jönsson, S. (2021). Pharmacometrics-Based Considerations for the Design of a Pharmacogenomic Clinical Trial Assessing Irinotecan Safety. Pharm Res.
استشهاد بنمط شيكاغوMinichmayr, Iris K., Mats O. Karlsson, و Siv Jönsson. "Pharmacometrics-Based Considerations for the Design of a Pharmacogenomic Clinical Trial Assessing Irinotecan Safety." Pharm Res 2021.
MLA استشهادMinichmayr, Iris K., Mats O. Karlsson, و Siv Jönsson. "Pharmacometrics-Based Considerations for the Design of a Pharmacogenomic Clinical Trial Assessing Irinotecan Safety." Pharm Res 2021.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.